Immunologic characterization of children vertically infected with human immunodeficiency virus, with slow or rapid disease progression.
about
T helper cell activation and human retroviral pathogenesisRecombinant human gamma interferon in human immunodeficiency virus-infected children: safety, CD4(+)-lymphocyte count, viral load, and neutrophil function (AIDS Clinical Trials Group Protocol 211)Macaques with rapid disease progression and simian immunodeficiency virus encephalitis have a unique cytokine profile in peripheral lymphoid tissues.Cytokine production in cell culture by peripheral blood mononuclear cells from immunocompetent hostsDiagnosis of human immunodeficiency virus infection using an immunoglobulin E-based assay.Type 1/Type 2 immunity in infectious diseases.TH1 and TH2 cytokine mRNA and protein levels in human immunodeficiency virus (HIV)-seropositive and HIV-seronegative youthsType 1 and type 2 cytokine profiles in children exposed to or infected with vertically transmitted human immunodeficiency virus.Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.The breakdown of the cytokine network subsequent to human immunodeficiency virus infection.The basics and advances of immunomodulators and antigen presentation: a key to development of potent memory response against pathogens.Increased serum IgE in alcoholics: relationship with Th1/Th2 cytokine production by stimulated blood mononuclear cells.Relationship of virologic, immunologic, and clinical parameters in infants with vertically acquired human immunodeficiency virus type 1 infection.Interferon-Gamma and Interleukin-10 Production Among HIV-1–Infected and Uninfected Infants of HIV-1–Infected MothersType 1 and Type 2 Cytokines in HIV Infection – A Possible Role in Apoptosis and Disease Progression
P2860
Q24650854-842F2683-3B57-4085-960D-CD72E6D95558Q33637000-F6859B0A-9996-409D-BC6C-352896727B81Q33840048-172CE429-8F35-4859-A375-67FB06FE4FECQ33993426-C1D4E071-C5F4-4604-B14A-B3D67A3C3D56Q33998113-92388F93-34D0-40FA-A454-F69EB4C07327Q34105379-FBC58EF7-D912-4BAE-9173-9ABB3EF98077Q34995781-9FDC2C8C-C45A-4E21-9B9D-D1E52974F0C8Q35227609-7785A2A5-FCCE-4995-AD58-3250C78FDAEBQ35372676-5CFC5091-47B8-469D-91E5-3E3E291C97FDQ36627792-1022B316-5537-44B0-AC56-06E814BAA3D6Q38217630-0CF389CB-E7F6-4D7F-8811-FE38D4C2689AQ43707115-374919B7-EF79-4318-A95E-0D4514335EFEQ45766906-01F06B0D-A4CD-4C65-B494-6E3C80019950Q57997577-A50F934F-427B-49A8-BAF7-5E2A35231B2EQ57997715-F503F64A-1CF0-4ABE-B3A5-C9F0563E61D7
P2860
Immunologic characterization of children vertically infected with human immunodeficiency virus, with slow or rapid disease progression.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Immunologic characterization o ...... or rapid disease progression.
@en
Immunologic characterization o ...... or rapid disease progression.
@nl
type
label
Immunologic characterization o ...... or rapid disease progression.
@en
Immunologic characterization o ...... or rapid disease progression.
@nl
prefLabel
Immunologic characterization o ...... or rapid disease progression.
@en
Immunologic characterization o ...... or rapid disease progression.
@nl
P2093
P1476
Immunologic characterization o ...... w or rapid disease progression
@en
P2093
P304
P356
10.1016/S0022-3476(95)70450-7
P407
P577
1995-03-01T00:00:00Z